Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dedifferentiated chondrosarcoma.
Mercuri M, Picci P, Campanacci L, Rulli E. Mercuri M, et al. Among authors: rulli e. Skeletal Radiol. 1995 Aug;24(6):409-16. doi: 10.1007/BF00941235. Skeletal Radiol. 1995. PMID: 7481896
Scoliosis due to nonosteogenic fibroma of the L2 lamina.
Macchiagodena M, Di Silvestre M, Rulli E, Parisini P. Macchiagodena M, et al. Among authors: rulli e. Orthopedics. 2005 May;28(5):499-500. doi: 10.3928/0147-7447-20050501-19. Orthopedics. 2005. PMID: 15945608 No abstract available.
Lumbar disc herniation in the elderly patient.
Di Silvestre M, Greggi T, Rulli E, Paderni S, Palumbi P, Parisini P. Di Silvestre M, et al. Among authors: rulli e. Chir Organi Mov. 2001 Jul-Sep;86(3):223-30. Chir Organi Mov. 2001. PMID: 12025186 English, Italian.
Rising Concern About the Carcinogenetic Role of Micro-Nanoplastics.
Ruggieri L, Amato O, Marrazzo C, Nebuloni M, Dalu D, Cona MS, Gambaro A, Rulli E, La Verde N. Ruggieri L, et al. Among authors: rulli e. Int J Mol Sci. 2024 Dec 30;26(1):215. doi: 10.3390/ijms26010215. Int J Mol Sci. 2024. PMID: 39796071 Free PMC article. Review.
TRAbectedin in adVanced rEtroperitoneal well differentiated/dedifferentiated Liposarcoma and Leiomyosarcoma (TRAVELL): results of a phase II study from the Italian Sarcoma Group.
Fabbroni C, Grignani G, Vincenzi B, Fumagalli E, De Pas TM, Mazzocca A, Pantaleo MA, Brunello A, Baldi GG, Boglione A, Fatigoni S, Berruti A, Giordano M, Marrari A, Dei Tos AP, Alberton AS, Aliberti S, Carlucci L, Rulli E, Casali PG, Sanfilippo R. Fabbroni C, et al. Among authors: rulli e. ESMO Open. 2024 Aug;9(8):103667. doi: 10.1016/j.esmoop.2024.103667. Epub 2024 Aug 8. ESMO Open. 2024. PMID: 39121815 Free PMC article. Clinical Trial.
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial.
Colombo N, Biagioli E, Harano K, Galli F, Hudson E, Antill Y, Choi CH, Rabaglio M, Marmé F, Marth C, Parma G, Fariñas-Madrid L, Nishio S, Allan K, Lee YC, Piovano E, Pardo B, Nakagawa S, McQueen J, Zamagni C, Manso L, Takehara K, Tasca G, Ferrero A, Tognon G, Lissoni AA, Petrella M, Laudani ME, Rulli E, Uggeri S, Barretina Ginesta MP; AtTEnd study group. Colombo N, et al. Among authors: rulli e. Lancet Oncol. 2024 Sep;25(9):1135-1146. doi: 10.1016/S1470-2045(24)00334-6. Epub 2024 Aug 2. Lancet Oncol. 2024. PMID: 39102832 Clinical Trial.
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671).
Proto C, Ganzinelli M, Manglaviti S, Imbimbo M, Galli G, Marabese M, Zollo F, Alvisi MF, Perrino M, Cordua N, Borea F, de Vincenzo F, Chella A, Cappelli S, Pardini E, Ballatore Z, Lucarelli A, Ambrosini E, Giuliano M, Pietroluongo E, Mulargiu C, Fabbri A, Prelaj A, Occhipinti M, Brambilla M, Mazzeo L, Beninato T, Vigorito R, Ruggirello M, Greco FG, Calareso G, Miliziano D, Rulli E, De Simone I, Torri V, de Braud FGM, Pasello G, De Placido P, Berardi R, Petrini I, Zucali P, Garassino MC, Lo Russo G. Proto C, et al. Among authors: rulli e. Ann Oncol. 2024 Sep;35(9):817-826. doi: 10.1016/j.annonc.2024.06.002. Epub 2024 Jun 8. Ann Oncol. 2024. PMID: 38857846 Free article. Clinical Trial.
Antibody response to three-dose anti-SARS-CoV-2 mRNA-vaccination in treated solid cancer patients.
Dalu D, Tarkowski M, Ruggieri L, Cona MS, Gabrieli A, De Francesco D, Fasola C, Ferrario S, Gambaro A, Masedu E, Parma G, Rulli E, De Stradis C, Mavilio D, Calcaterra F, Manoni F, Riva A, La Verde N. Dalu D, et al. Among authors: rulli e. Int J Cancer. 2024 Apr 15;154(8):1371-1376. doi: 10.1002/ijc.34817. Epub 2023 Dec 15. Int J Cancer. 2024. PMID: 38100252 Free article.
147 results